The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.
The technology is intended for U.S. service members but expected to be used widely by civilians.
The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.
The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.
CRAB Alert: The EVS Role in Preventing Infection
Why Hospital Waiting Rooms Aren't Going Away
Ground Broken on Mount Sinai Tisch Cancer Hospital
Design, Compartmentation, Training: How Defend-in-Place Strategies Can Protect Patients
Milestone Marked with Topping Out Ceremony for BayCare Hospital Manatee